Luxi Ye
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
-
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 5
- Occupational and environmental lung diseases 1
- Oncology 7
- Inflammatory Biomarkers in Disease Prognosis 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Jian He (9 shared papers)Shiming Shi (10 shared papers)Zhao‐Chong Zeng (10 shared papers)Jianjiao Ni (9 shared papers)Liqing Zou (7 shared papers)Xi Yang (9 shared papers)Zhengfei Zhu (9 shared papers)Xiao Chu (8 shared papers)
- Journals
- Translational Lung Cancer Research (2 papers)Japanese Journal of Clinical Oncology (2 papers)Journal of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Luxi Ye
25 papers receiving 286 citations
Peers
Comparison fields: 5 of 37
- Pulmonary and Respiratory Medicine 121
- Oncology 100
- Radiology, Nuclear Medicine and Imaging 52
- Otorhinolaryngology 7
- Radiation 14
Countries citing papers authored by Luxi Ye
This map shows the geographic impact of Luxi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luxi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luxi Ye more than expected).
Fields of papers citing papers by Luxi Ye
This network shows the impact of papers produced by Luxi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luxi Ye. The network helps show where Luxi Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Luxi Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 37 | |
| 2 | 2020 | 33 | |
| 3 | 2020 | 30 | |
| 4 | 2021 | 29 | |
| 5 | 2020 | 23 | |
| 6 | 2017 | 20 | |
| 7 | 2017 | 15 | |
| 8 | 2016 | 14 | |
| 9 | 2019 | 13 | |
| 10 | 2016 | 12 | |
| 11 | 2021 | 12 | |
| 12 | 2017 | 8 | |
| 13 | 2019 | 8 | |
| 14 | 2020 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2019 | 3 | |
| 20 | 2017 | 2 |
About Luxi Ye
Luxi Ye is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiation and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 289 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Advanced Radiotherapy Techniques (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Effects of Radiation Exposure (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Occupational and environmental lung diseases (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (121 citations), Oncology (100 citations), Radiology, Nuclear Medicine and Imaging (52 citations), Otorhinolaryngology (7 citations) and Radiation (14 citations). Luxi Ye has collaborated with scholars based in China and United States. Frequent co-authors include Jian He, Shiming Shi, Zhao‐Chong Zeng, Jianjiao Ni, Liqing Zou, Xi Yang, Zhengfei Zhu, Xiao Chu, Tiantian Guo and Yue Zhou. Their work appears in journals such as Translational Lung Cancer Research, Japanese Journal of Clinical Oncology, Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.